ACRO Medical pairs academic rigor with operational discipline. This piece summarizes our perspective and the reasoning behind it.
Why it matters
Evidence-grounded decisions reduce downstream risk across the trial lifecycle.
The protocols that survive review are the ones where the cleverness serves a decision the reviewer can recognize.
What we recommend
- Pre-specify decisions, not just analyses.
- Align biostatistics and regulatory strategy early.
- Validate assumptions with real-world data.